P
Payal
About Payal
Data last updated:
Payal is a Director at Pps Nervecure Pharmaceuticals India Private Limited (since 2023). The companies operate in Pharma and Trading. Earlier, Payal was a Director at Antares Pharmaceuticals Private Limited (2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Pps Nervecure Pharmaceuticals India Private Limited U46497DL2023PTC423337 | Director | 01 Dec 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Antares Pharmaceuticals Private Limited U51909DL2022PTC395567 | Director | 25 Mar 2022 | 2022 | ₹23.9 Lakh (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Payal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Prince | 10412248 | Pps Nervecure Pharmaceuticals India Private Limited | Director |
| Sunita Rani | 10412249 | Pps Nervecure Pharmaceuticals India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Payal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Payal
Payal currently holds 1 directorship: Pps Nervecure Pharmaceuticals India Private Limited (Director, since 01 Dec 2023).
Payal was first appointed on 25 Mar 2022 as Director at Antares Pharmaceuticals Private Limited. The most recent appointment on record is 01 Dec 2023 at Pps Nervecure Pharmaceuticals India Private Limited.
Payal held 1 earlier board appointment: Antares Pharmaceuticals Private Limited (Director, 25 Mar 2022 to 21 Oct 2022).
The current boards of Payal's companies include Prince (Pps Nervecure Pharmaceuticals India Private Limited), Sunita Rani (Pps Nervecure Pharmaceuticals India Private Limited).